LGR5-KD reduced WNT/β-catenin pathway activation and LGR5 overexpression led to elevated TCF/LEF activity and induced WNT/ β-catenin pathway in HCC cells (HuH-7) [99]. The gene discussed is LGR5; the disease is hepatocellular carcinoma.